Platelet count: a simple measure of activity in Crohn's disease.
作者信息
Harries A D, Fitzsimons E, Fifield R, Dew M J, Rhoades J
出版信息
Br Med J (Clin Res Ed). 1983 May 7;286(6376):1476. doi: 10.1136/bmj.286.6376.1476.
Abstract
摘要
相似文献
1
Platelet count: a simple measure of activity in Crohn's disease.血小板计数：克罗恩病活动度的一项简易指标。
Br Med J (Clin Res Ed). 1983 May 7;286(6376):1476. doi: 10.1136/bmj.286.6376.1476.
2
Platelet number and size in relation to serum orosomucoid concentration in Crohn's disease.克罗恩病中血小板数量和大小与血清类粘蛋白浓度的关系
Med Lab Sci. 1989 Jan;46(1):79-80.
3
Platelet count in patients with Crohn's disease.克罗恩病患者的血小板计数
Br Med J (Clin Res Ed). 1983 Jun 11;286(6381):1895-6. doi: 10.1136/bmj.286.6381.1895-a.
4
[Use of the ratio of orosomucoid and prealbumin values as an indicator of the activity of Crohn's disease].[使用类黏蛋白与前白蛋白值的比值作为克罗恩病活动度的指标]
Cas Lek Cesk. 1982 Dec;121(48):1493-4.
5
Platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios in Crohn's disease: The controversy remains.克罗恩病中血小板与淋巴细胞及中性粒细胞与淋巴细胞的比值：争议犹存。
Clin Res Hepatol Gastroenterol. 2018 Feb;42(1):e16-e18. doi: 10.1016/j.clinre.2017.07.001. Epub 2017 Aug 7.
6
The acute phase protein response in Crohn's colitis.克罗恩病性结肠炎中的急性期蛋白反应。
Biochem Soc Trans. 1991 Apr;19(2):222S. doi: 10.1042/bst019222s.
7
Soluble interleukin-2 receptor in Crohn's disease: relation of serum concentrations to disease activity.克罗恩病中的可溶性白细胞介素-2受体：血清浓度与疾病活动度的关系
Gut. 1990 Sep;31(9):1033-6. doi: 10.1136/gut.31.9.1033.
8
Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators.甲氨蝶呤用于治疗克罗恩病。北美克罗恩病研究组研究者。
N Engl J Med. 1995 Feb 2;332(5):292-7. doi: 10.1056/NEJM199502023320503.
9
Assessment of appropriate laboratory measurements to supplement the Crohn's disease activity index.评估补充克罗恩病活动指数的适当实验室检测指标。
Gut. 1981 Jul;22(7):571-4. doi: 10.1136/gut.22.7.571.
引用本文的文献
1
Effects of COVID-19 vaccines on patient-reported outcomes in patients with inflammatory bowel disease: a multicenter survey study in Korea.新型冠状病毒肺炎疫苗对炎症性肠病患者自我报告结局的影响：韩国一项多中心调查研究
Intest Res. 2024 Jul;22(3):336-350. doi: 10.5217/ir.2023.00077. Epub 2024 Mar 26.
2
Dysregulated haemostasis in thrombo-inflammatory disease.血栓炎症性疾病中的血液失调。
Clin Sci (Lond). 2022 Dec 22;136(24):1809-1829. doi: 10.1042/CS20220208.
3
Therapeutic efficacy of rifaximin loaded tamarind gum polysaccharide nanoparticles in TNBS induced IBD model Wistar rats.罗氟沙星负载罗望子胶多糖纳米颗粒在三硝基苯磺酸诱导的Wistar大鼠炎症性肠病模型中的治疗效果
Rep Pract Oncol Radiother. 2021 Sep 30;26(5):712-729. doi: 10.5603/RPOR.a2021.0100. eCollection 2021.
4
The risk of venous thromboembolic events in patients with inflammatory bowel disease: a systematic review and meta-analysis.炎症性肠病患者发生静脉血栓栓塞事件的风险：一项系统评价和荟萃分析。
Ann Gastroenterol. 2021 Sep-Oct;34(5):680-690. doi: 10.20524/aog.2021.0631. Epub 2021 May 27.
5
Risk of venous thromboembolism in immune-mediated inflammatory diseases: a UK matched cohort study.免疫介导的炎症性疾病患者静脉血栓栓塞风险：一项英国匹配队列研究。
RMD Open. 2020 Sep;6(3). doi: 10.1136/rmdopen-2020-001392.
6
Platelet factor 4 is a biomarker for lymphatic-promoted disorders.血小板因子 4 是一种淋巴促进性疾病的生物标志物。
JCI Insight. 2020 Jul 9;5(13):135109. doi: 10.1172/jci.insight.135109.
7
Whole-Genome DNA Methylation Profiling of CD14+ Monocytes Reveals Disease Status and Activity Differences in Crohn's Disease Patients.CD14+单核细胞的全基因组DNA甲基化分析揭示克罗恩病患者的疾病状态和活动差异
J Clin Med. 2020 Apr 8;9(4):1055. doi: 10.3390/jcm9041055.
8
Combined Use of Common Fecal and Blood Markers for Detection of Endoscopically Active Inflammatory Bowel Disease.联合使用常见粪便和血液标志物检测内镜下活动性炎症性肠病
Clin Transl Gastroenterol. 2020 Mar;11(3):e00138. doi: 10.14309/ctg.0000000000000138.
9
ADAMTS13 Deficiency Worsens Colitis and Exogenous ADAMTS13 Administration Decreases Colitis Severity in Mice.ADAMTS13缺乏会加重小鼠结肠炎，而外源性给予ADAMTS13可减轻小鼠结肠炎的严重程度。
TH Open. 2017 Jun;1(1):e11-e23. doi: 10.1055/s-0037-1603927.
10
Serum platelet factor 4 is a reliable activity parameter in adult patients with inflammatory bowel disease: A pilot study.血清血小板因子4是成年炎症性肠病患者的可靠活性参数：一项初步研究。
Medicine (Baltimore). 2017 Mar;96(11):e6323. doi: 10.1097/MD.0000000000006323.
本文引用的文献
1
Assessment of appropriate laboratory measurements to supplement the Crohn's disease activity index.评估补充克罗恩病活动指数的适当实验室检测指标。
Gut. 1981 Jul;22(7):571-4. doi: 10.1136/gut.22.7.571.
2
A simple index of Crohn's-disease activity.克罗恩病活动度的简易指数。
Lancet. 1980 Mar 8;1(8167):514. doi: 10.1016/s0140-6736(80)92767-1.
3
Thrombocytosis in chronic inflammatory bowel disease.慢性炎症性肠病中的血小板增多症。
Ann Intern Med. 1968 May;68(5):1013-21. doi: 10.7326/0003-4819-68-5-1013.
4
Thrombocytosis in ulcerative colitis and Crohn's disease.溃疡性结肠炎和克罗恩病中的血小板增多症。
Scand J Gastroenterol. 1973;8(2):135-8.
5
Coagulation studies in ulcerative colitis and Crohn's disease.
Gastroenterology. 1975 Feb;68(2):245-51.
Zotero 插件